Inventor
DI FRANCESCO MARIA EMILIA
US34 patents
⚠️ This page may combine multiple inventors who share the name “DI FRANCESCO MARIA EMILIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TEXAS
20 patentsUS10344025B2Jul 9, 2019
GLS1 inhibitors for treating disease
UNIV TEXAS12 citations91
US9809588B2Nov 7, 2017
GLS1 inhibitors for treating disease
UNIV TEXAS15 citations91
US11370786B2Jun 28, 2022
GLS1 inhibitors for treating disease
UNIV TEXAS6 citations84
US10766892B2Sep 8, 2020
GLS1 inhibitors for treating disease
UNIV TEXAS9 citations83
US10421765B2Sep 24, 2019
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
UNIV TEXAS7 citations82
US10392376B2Aug 27, 2019
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS7 citations82
US11400108B2Aug 2, 2022
Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
UNIV TEXAS1 citations73
US10933078B2Mar 2, 2021
Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
UNIV TEXAS2 citations73
US10363248B2Jul 30, 2019
Salts of heterocyclic modulators of HIF activity for treatment of disease
UNIV TEXAS2 citations73
US11958849B2Apr 16, 2024
GLS1 inhibitors for treating disease
UNIV TEXAS2 citations72
US11001594B2May 11, 2021
Heterocyclic modulators of HIF activity for treatment of disease
UNIV TEXAS1 citations72
US10800769B2Oct 13, 2020
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS2 citations71
US10800774B2Oct 13, 2020
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS2 citations71
US10745420B2Aug 18, 2020
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
UNIV TEXAS2 citations71
US12036231B2Jul 16, 2024
Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
UNIV TEXAS0 citations62
US10888554B2Jan 12, 2021
Salts of heterocyclic modulators of HIF activity for treatment of disease
UNIV TEXAS0 citations62
US11725008B2Aug 15, 2023
Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
UNIV TEXAS0 citations61
US11434233B2Sep 6, 2022
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS0 citations61
US11028083B2Jun 8, 2021
Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
UNIV TEXAS1 citations61
US10894052B2Jan 19, 2021
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS1 citations61
ALTMAN MICHAEL D
4 patentsUS8551984B2Oct 8, 2013
Aminopyrimidines as SYK inhibitors
ALTMAN MICHAEL D25 citations90
US9120785B2Sep 1, 2015
Pyridyl aminopyridines as Syk inhibitors
ALTMAN MICHAEL D13 citations83
US9290490B2Mar 22, 2016
Aminopyrimidines as Syk inhibitors
ALTMAN MICHAEL D12 citations82
US9216173B2Dec 22, 2015
2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
ALTMAN MICHAEL D8 citations82
MERCK SHARP & DOHME
4 patentsUS9006444B2Apr 14, 2015
Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
MERCK SHARP & DOHME13 citations83
US8377873B2Feb 19, 2013
HCV NS3 protease inhibitors
MERCK SHARP & DOHME9 citations82
US9487504B2Nov 8, 2016
Imidazolyl analogs as syk inhibitors
MERCK SHARP & DOHME1 citations50
US9598405B2Mar 21, 2017
Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
MERCK SHARP & DOHME0 citations40